Q: How much cash/share does Knight Therapeutics have? Thanks.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: To add to what Steven comment today on the Company. I respect M. Goodman view on the long term goals of the company. His analogy for is "grandchildren" and stockholders would make sense if at the very least a dividend would be paid for waiting.
This would a small way to compensate to the shareholders while we are supporting the company.
This would a small way to compensate to the shareholders while we are supporting the company.
Q: what exactly is medison fighting for and how much of a lock does goodman have on knight.
dave
dave
Q: High volume at the close. My guess is insiders did the buying, if so how many days before they have to disclose ?
Also I noticed that for my last 2 questions I did not receive the answer by email but saw the answer on your site. Has something changed ?
Thanks for your help.
Also I noticed that for my last 2 questions I did not receive the answer by email but saw the answer on your site. Has something changed ?
Thanks for your help.
Q: Hi. Any news on what happened with GUD in the last 20 minutes? Thanks
-
Knight Therapeutics Inc. (GUD $6.45)
-
BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH $65.48)
Q: I have very little in the health care industry, I only own GUD at 1.5% of my portfolio. I am thinking of selling GUD and buying ZUH at say 2.5% of my portfolio. Your thoughts please. Or would you suggest some other health ETF?
Q: I completely understand your support for Johnathan Goodman at Knight as his history is beyond impressive. However, I think Mr. Jakobsohn's proposal asks some significant questions that, as a shareholder, I would like to hear answers for. It does make me uncomfortable that his family company got involved in four deals and he will benefit more than if he had Knight involved. That seems like a legitimate concern as is the puny revenues generated in four years since Knight's launch. Conversely, Knight provided Medisen the opportunity to thrive and succeed and it is not the first time I have seen beneficiaries conveniently forget who helped them become successful once they have achieved momentum and no longer need their benefactor.
Ultimately, I do hope this exercise will help Goodman see some valid points in Jakobsohn's presentation and diversify his board and spend some cash. The articles that have appeared about Goodman detail his bargaining savvy but who would want to deal with him when it is public knowledge he has a desire to buy for nothing... I wish he would forget about his famous "grandchildren" analogy and show the investors who have supported his financings and bought the stock at $10 plus that he can still discover companies with potential and make mutually beneficial deals so Knight can thrive and grow.
I doubt Jakobsohn's proposal will go anywhere but perhaps it will reinforce to Goodman that his approach could be a little more "in the present" to his many investors/supporters.
I have a bad case of FOMO when it comes to Knight. If I liquidate part or all of my shares, I stress about Goodman making a blockbuster deal the next day!!
Would you agree with anything I have said and please provide an opinion on any value in the dissenting proposal.
Thanks.
Ultimately, I do hope this exercise will help Goodman see some valid points in Jakobsohn's presentation and diversify his board and spend some cash. The articles that have appeared about Goodman detail his bargaining savvy but who would want to deal with him when it is public knowledge he has a desire to buy for nothing... I wish he would forget about his famous "grandchildren" analogy and show the investors who have supported his financings and bought the stock at $10 plus that he can still discover companies with potential and make mutually beneficial deals so Knight can thrive and grow.
I doubt Jakobsohn's proposal will go anywhere but perhaps it will reinforce to Goodman that his approach could be a little more "in the present" to his many investors/supporters.
I have a bad case of FOMO when it comes to Knight. If I liquidate part or all of my shares, I stress about Goodman making a blockbuster deal the next day!!
Would you agree with anything I have said and please provide an opinion on any value in the dissenting proposal.
Thanks.
Q: In response to a recent question about GUD, you mentioned that "there is an unhappy shareholder and board member who wants some changes made at the company". Could you please provide more detail about why he/she is unhappy and what changes they would like to be made? Thank you.
Q: Hello 5i team,
I was looking at the GUD chart and noticed a very high volume of trading in the last week. The last time there was any volume this comparable was 2 years ago.
Is there anything news wise going on with Knight Therapeutics?
Andrew
I was looking at the GUD chart and noticed a very high volume of trading in the last week. The last time there was any volume this comparable was 2 years ago.
Is there anything news wise going on with Knight Therapeutics?
Andrew
Q: Not a question just a statement. Here is a reminder for us long term holders of Knight Therapeutics on what the investment horizon may be.
"For investors, if their investment horizon is not their grandchildren, we are not the right company for them. Paladin had 19 years of record revenues but for 12 of those years, our stock was flat. It took us 19 years to become an overnight success." - Jonathan Ross Goodman
"For investors, if their investment horizon is not their grandchildren, we are not the right company for them. Paladin had 19 years of record revenues but for 12 of those years, our stock was flat. It took us 19 years to become an overnight success." - Jonathan Ross Goodman
Q: Please comment on quarterly results when you get a chance.
Q: I am compiling a list of companies that have a large cash pile and a track record of being acquisitive and who might exploit opportunities efficiently during a recession, or other negative market event. Who would you put at the top five on that list? Thank-you.
-
Xilinx Inc. (XLNX)
-
Salesforce Inc. (CRM $248.29)
-
Enghouse Systems Limited (ENGH $22.78)
-
Pason Systems Inc. (PSI $12.02)
-
Knight Therapeutics Inc. (GUD $6.45)
Q: Good Afternoon 5i,
I'm looking for companies that have little to no debt, high growth in Canada or the USA.
Some companies I hold include (which I believe meet this criteria): SHOP, KXS, NVDA, SQ, MU, GOOS.
Can you provide a few more that you like that meet this criteria?
Thanks!
Dave
I'm looking for companies that have little to no debt, high growth in Canada or the USA.
Some companies I hold include (which I believe meet this criteria): SHOP, KXS, NVDA, SQ, MU, GOOS.
Can you provide a few more that you like that meet this criteria?
Thanks!
Dave
Q: Hi, I see that Knight is at a two year low. I like the company for it’s conservative ways, comfort if recession hits, and large cash position. (Has it ever given a one time special dividend while waiting?). I will be buying more in the near future.
Is now a good time to buy or would you wait and if it hits the low RSI ,as momentum is weak? I have a 4% position
Thanks,
Is now a good time to buy or would you wait and if it hits the low RSI ,as momentum is weak? I have a 4% position
Thanks,
-
Bank of Nova Scotia (The) (BNS $79.70)
-
Sun Life Financial Inc. (SLF $81.49)
-
TELUS Corporation (T $22.94)
-
Stantec Inc. (STN $153.25)
-
Kinaxis Inc. (KXS $194.59)
-
Knight Therapeutics Inc. (GUD $6.45)
-
Savaria Corporation (SIS $21.15)
Q: Long term TFSA. I am currently down 11%BNS;26%GUD;8%STN and 6%SLF. Have Plus 10% weightings in all 7 stocks.
Should I add to the (current) losers or add something new or add to my (current) winners.
Should I add to the (current) losers or add something new or add to my (current) winners.
Q: I notice that Raymond James has recently given an outperform rating to GUD. I am wondering on what possible basis they could do this? This is not just an idle question. Because if they know something that I don't know, I may buy more.
thanks
thanks
Q: I know that no one is making any money on this corpse of a stock.
But to share my success with it, I wanted to let readers now that it can be a very consistent and profitable trade vs investment.
Over the past 16 months I have purchased GUD between 7.5 and 7.7 and sold in the mid to hi $8 range.
Just opened my most recent long yesterday at 7.60.
FWIW.
Sheldon
But to share my success with it, I wanted to let readers now that it can be a very consistent and profitable trade vs investment.
Over the past 16 months I have purchased GUD between 7.5 and 7.7 and sold in the mid to hi $8 range.
Just opened my most recent long yesterday at 7.60.
FWIW.
Sheldon
Q: I saw your comments on GUD and they make sense. But if I told you I owned a stock that has been down 25 percent for 2 years and that it continually disappoints shareholders, (GUD took in only about 11 million in REVENUE last year, despite a market cap of 1.1 billion and 750 million cash sitting on the balance sheet. This is mind boggling, really) I think your answer would be that it's dead money and that I should move on. So while this might end up being a good long term investment for 'my grandchildren', it really doesn't seem to fit with your overall philosophy, does it?
Q: Comments on the latest conjecture this morning?
Q: Hi All at 5i! I hold GUD, but was wondering if I should swap it out for MU. I am looking for growth. What would you suggest? Cheers, Tamara